Effect of lanthanum carbonate on medical cost and laboratory values in hemodialysis patients with hyperphosphatemia
Not Applicable
- Conditions
- Hyperphosphatemia
- Registration Number
- JPRN-UMIN000002058
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1, The patients who don't agree with this study 2, The patients who are judged inappropriate for the study by the physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1, Change in phosphate, calcium, and parathyroid hormone before and after lanthanum carbonate treatment. 2, Change in the dose of calcium containing phosphate binder, sevelamer, vitamin D analogues, and cinacalcet. 3, Medical cost of lanthanum carbonate
- Secondary Outcome Measures
Name Time Method Side effect of lanthanum carbonate